Distinct roles for RB loss on cell cycle control, cisplatin response, and immortalization in Schwann cells

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 205-217

  Seeley, Sarah L ^a   Bosco, Emily E ^a   Kramer, Elizabeth ^a   Parysek, Linda M ^a   Knudsen, Erik S ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cell cycle; Cisplatin; Cyclin; E2F; Retinoblastoma; Tumor suppressor

Indexed keywords

CISPLATIN; GENE PRODUCT; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER GROWTH; CELL CYCLE REGULATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; MITOGENESIS; MOUSE; NERVE FUNCTION; NERVE INJURY; NERVE SHEATH TUMOR; NEURINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINOBLASTOMA; SCHWANN CELL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CISPLATIN; GANGLIA, SPINAL; GENE DELETION; MICE; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, NERVE GROWTH FACTOR; RETINOBLASTOMA PROTEIN; SCHWANN CELLS;

EID: 33845613065     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.028     Document Type: Article

References (48)

1. Stevens B., and Fields R.D. Regulation of the cell cycle in normal and pathological glia. Neuroscientist 8 (2002) 93-97
2. Atanasoski S., Shumas S., Dickson C., Scherer S.S., and Suter U. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol. Cell. Neurosci. 18 (2001) 581-592
3. Dasgupta B., and Gutmann D.H. Neurofibromatosis 1: closing the GAP between mice and men. Curr. Opin. Genet. Dev. 13 (2003) 20-27
4. Baser M.E., Friedman J.M., Aeschliman D., Joe H., Wallace A.J., Ramsden R.T., et al. Predictors of the risk of mortality in neurofibromatosis 2. Am. J. Hum. Genet. 71 (2002) 715-723
5. Ferner R.E., and O'Doherty M.J. Neurofibroma and schwannoma. Curr. Opin. Neurol. 15 (2002) 679-684
6. Evans D.G., Baser M.E., McGaughran J., Sharif S., Howard E., and Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J. Med. Genet. 39 (2002) 311-314
7. Carroll S.L., and Stonecypher M.S. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling. J. Neuropathol. Exp. Neurol. 64 (2005) 1-9
8. Agesen T.H., Florenes V.A., Molenaar W.M., Lind G.E., Berner J.M., Plaat B.E., et al. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol. 64 (2005) 74-81
9. Birindelli S., Perrone F., Oggionni M., Lavarino C., Pasini B., Vergani B., et al. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab. Invest. 81 (2001) 833-844
10. Wang J.Y., Knudsen E.S., and Welch P.J. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64 (1994) 25-85
11. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
12. Weinberg R.A. The retinoblastoma gene and gene product. Cancer Surv. 12 (1992) 43-57
13. Bartek J., Bartkova J., and Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237 (1997) 1-6
14. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
15. Malumbres M., and Carnero A. Cell cycle deregulation: a common motif in cancer. Prog. Cell Cycle Res. 5 (2003) 5-18
16. Malumbres M., and Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1 (2001) 222-231
17. Mittnacht S. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8 (1998) 21-27
18. Mawrin C., Kirches E., Boltze C., Dietzmann K., Roessner A., and Schneider-Stock R. Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch. 440 (2002) 610-615
19. Morris E.J., and Dyson N.J. Retinoblastoma protein partners. Adv. Cancer Res. 82 (2001) 1-54
20. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101 (2000) 79-89
21. Yu J.T., Foster R.G., and Dean D.C. Transcriptional repression by RB-E2F and regulation of anchorage-independent survival. Mol. Cell. Biol. 21 (2001) 3325-3335
22. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391 (1998) 601-605
23. Zhang H.S., Postigo A.A., and Dean D.C. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 97 (1999) 53-61
24. Markey M.P., Angus S.P., Strobeck M.W., Williams S.L., Gunawardena R.W., Aronow B.J., et al. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 62 (2002) 6587-6597
25. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., and Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70 (1992) 993-1006
26. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., and Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98 (1999) 859-869
27. Knudsen E.S., and Wang J.Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17 (1997) 5771-5783
28. Xiao G.H., Gallagher R., Shetler J., Skele K., Altomare D.A., Pestell R.G., et al. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol. Cell. Biol. 25 (2005) 2384-2394
29. Morrison H., Sherman L.S., Legg J., Banine F., Isacke C., Haipek C.A., et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15 (2001) 968-980
30. Kim H.A., Ratner N., Roberts T.M., and Stiles C.D. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. J. Neurosci. 21 (2001) 1110-1116
31. Vooijs M., Jonkers J., Lyons S., and Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 62 (2002) 1862-1867
32. Vooijs M., te Riele H., van der Valk M., and Berns A. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21 (2002) 4635-4645
33. Delree P., Leprince P., Schoenen J., and Moonen G. Purification and culture of adult rat dorsal root ganglia neurons. J. Neurosci. Res. 23 (1989) 198-206
34. Knudsen E.S., Buckmaster C., Chen T.T., Feramisco J.R., and Wang J.Y. Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev. 12 (1998) 2278-2292
35. Sever-Chroneos Z., Angus S.P., Fribourg A.F., Wan H., Todorov I., Knudsen K.E., et al. Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase. Mol. Cell. Biol. 21 (2001) 4032-4045
36. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
37. Bosco E.E., Mayhew C.N., Hennigan R.F., Sage J., Jacks T., and Knudsen E.S. RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res. 32 (2004) 25-34
38. Mayhew C.N., Perkin L.M., Zhang X., Sage J., Jacks T., and Knudsen E.S. Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene 23 (2004) 4107-4120
39. Herrera R.E., Sah V.P., Williams B.O., Makela T.P., Weinberg R.A., and Jacks T. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16 (1996) 2402-2407
40. Chau B.N., and Wang J.Y. Coordinated regulation of life and death by RB. Nat. Rev. Cancer 3 (2003) 130-138
41. Thomas D.M., Yang H.S., Alexander K., and Hinds P.W. Role of the retinoblastoma protein in differentiation and senescence. Cancer Biol. Ther. 2 (2003) 124-130
42. Harrington E.A., Bruce J.L., Harlow E., and Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl Acad. Sci. USA 95 (1998) 11945-11950
43. Knudsen K.E., Booth D., Naderi S., Sever-Chroneos Z., Fribourg A.F., Hunton I.C., et al. RB-dependent S-phase response to DNA damage. Mol. Cell. Biol. 20 (2000) 7751-7763
44. Lan Z., Sever-Chroneos Z., Strobeck M.W., Park C.H., Baskaran R., Edelmann W., et al. DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2. J. Biol. Chem. 277 (2002) 8372-8381
45. Sellers W.R., Rodgers J.W., and Kaelin Jr. W.G. transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl Acad. Sci. USA 92 (1995) 11544-11548
46. Black E.P., Huang E., Dressman H., Rempel R., Laakso N., Asa S.L., et al. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 63 (2003) 3716-3723
47. Herrera R.E., Makela T.P., and Weinberg R.A. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7 (1996) 1335-1342
48. Harrisingh M.C., Perez-Nadales E., Parkinson D.B., Malcolm D.S., Mudge A.W., and Lloyd A.C. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. Eur. Mol. Biol. Org. J. 23 (2004) 3061-3071